OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CMPX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Compass Therapeutics (CMPX) Earnings Date & Reports

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CMPX is expected to report earnings to fall 6.43% to -13 cents per share on November 06

Compass Therapeutics CMPX Stock Earnings Reports

Q3'25

Est.

$-0.13

Q2'25

Missed

by $0.02

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.03

The last earnings report on August 11 showed earnings per share of -14 cents, missing the estimate of -11 cents. With 1.66M shares outstanding, the current market capitalization sits at 410.70M.

View a ticker or compare two or three

Compare

CMPX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CMPX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CMPX showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

80 Guest Street

Phone

+1 617 500-8099

Employees

Web

https://www.compasstherapeutics.com